CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....
Phase 1, Phase 2
Dallas, Texas, United States and 14 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Dallas, Texas, United States and 66 other locations
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Dallas, Texas, United States and 31 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Dallas, Texas, United States and 71 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Dallas, Texas, United States and 39 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Dallas, Texas, United States and 215 other locations
with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:* To improve the event-free su...
Phase 2, Phase 3
Fort Worth, Texas, United States and 7 other locations
choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy....
Phase 3
Fort Worth, Texas, United States and 112 other locations
dose escalation and expansion clinical trial to evaluate the safety, tolerability and PK of HMPL-689 in patients with relapsed or refractory lymphomas...
Phase 1
Dallas, Texas, United States and 26 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Dallas, Texas, United States and 58 other locations
Clinical trials
Research sites
Resources
Legal